N
Nykode Therapeutics ASA
OSE:NYKD
Nykode Therapeutics ASA
OSE:NYKD
Price:
14.67 NOK
-0.41%
Market Closed
Updated:
May 20, 2024
Section:
Relative Value
The Relative Value of one NYKD stock under the Base Case scenario is hidden NOK. Compared to the current market price of 14.67 NOK, Nykode Therapeutics ASA is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NYKD Relative Value
HIDDEN
Valuation Multiples
Multiples Across Competitors
NYKD Competitors Multiples
Nykode Therapeutics ASA Competitors
Nykode Therapeutics ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
N
|
Nykode Therapeutics ASA
OSE:NYKD
|
4.8B NOK | 34.8 | -12.8 | -5.4 | -5.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
293.9B USD | 5.4 | 49.4 | 13.8 | 21.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
167.6B USD | 5.7 | 44.5 | 18.7 | 30.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115B USD | 11.3 | 28.6 | 24 | 25.1 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.2B USD | 8.3 | 28.1 | 22.7 | 25.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.3B AUD | 6.4 | 36.6 | 22.1 | 27.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84.4B USD | 3.1 | 174.3 | 8.8 | 11.6 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
50.9B USD | 9.9 | -8.5 | -9.4 | -8.4 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.6B USD | 3.5 | 28.8 | 14.6 | 18.3 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.7T KRW | 18.2 | 74.1 | 45.3 | 62.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
